REGENERON PHARMAC.DL-,001
REGENERON PHARMAC.DL-,001/ US75886F1075 /
RGO
|
2025-03-16 6:02:52 PM
|
Chg.
0.00
|
Volume |
Bid6:02:52 PM |
Ask6:02:52 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
610.00EUR
|
0.00%
|
-
Turnover: - |
610.00Bid Size: - |
611.40Ask Size: - |
67 bill.EUR |
- |
- |
Fundamentals
| |
FY 2024 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
40.90 USD |
10.39% |
| EPS Diluted: |
38.34 USD |
10.27% |
| Revenues per Share: |
132.10 USD |
8.71% |
| Book Value per Share: |
273.04 USD |
13.47% |
| Cash Flow per Share: |
41.12 USD |
-3.39% |
| Dividend per Share: |
- USD |
- |
| Total |
in mill. |
|
| Revenues: |
14,202.00 USD |
8.27% |
| Net Income: |
4,412.60 USD |
11.61% |
| Operating Cash Flow: |
4,420.50 USD |
- |
| Cash and Cash Equivalents: |
2,488.20 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
16.30 |
17.42 |
| P/S Ratio: |
5.05 |
5.39 |
| P/BV ratio: |
2.44 |
2.61 |
| P/CF Ratio: |
16.22 |
17.32 |
| PEG: |
1.57 |
1.68 |
| Earnings Yield: |
6.13% |
5.74% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
67 bill. EUR |
73.99 bill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
- EUR |
- EUR |
| Shares Outstanding: |
107.51 mill. |
|
Profitability
| Gross Profit Margin: |
- |
| EBIT Margin: |
28.10% |
| Net Profit Margin: |
31.07% |
| Return on Equity: |
15.03% |
| Return on Assets: |
11.69% |
Financial Strength
| Liquidity I / Cash Ratio: |
0.63% |
| Liquidity II / Quick Ratio: |
2.21% |
| Liquidity III / Current Ratio: |
4.73% |
| Debt / Equity Ratio: |
0.09% |
| Dynam. Debt / Equity Ratio: |
190.16% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
2024-12-31 |
| Accounting Standard: |
US GAAP |
